Dark

Check out our API

CGIX
Cancer Genetics, Inc. Common Stock
stock NASDAQ

Inactive

Mar 30, 2021

4.61USD-2.331%(-0.11)612,486

Pre-market

Dec 31, 1969 7:00:00 PM EST

0.00USD-100.000%(-4.72)0

After-hours

Dec 31, 1969 7:00:00 PM EST

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Mar 31, 2021

06:30AM EDT Cancer Genetics and StemoniX Announce Merger Closing GlobeNewswire Inc

Mar 25, 2021

12:08PM EDT Mid-Day Market Update: Crude Oil Down Over 4%; Cellect Biotechnology Shares Surge Benzinga

09:19AM EDT Cancer Genetics Reports Results From Annual Shareholder Meeting Benzinga

09:15AM EDT Combined entity creates an innovative platform to de-risk and accelerate the discovery and development of preclinical and clinical pipelines with biopharma partners as well as the proprietary pipeline of the combined company GlobeNewswire Inc

Mar 18, 2021

08:30AM EDT Cancer Genetics, Inc. (the Company) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today the appointment of Roland J. Carrillo, PhD as the Vice President of Business Development. GlobeNewswire Inc

Mar 12, 2021

09:30AM EST Cancer Genetics, Inc. (the Company) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts, Chief Executive Officer, will present at the Annual 33rd ROTH Conference. The event is being held virtually from March 15-17, 2021. GlobeNewswire Inc

Mar 4, 2021

04:15PM EST Cancer Genetics, Inc. (the Company) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts, Chief Executive Officer, will present at H.C. Wainwrights Global Life Sciences Conference. The event is being held virtually from March 9-10, 2021. GlobeNewswire Inc

Feb 25, 2021

03:07PM EST Cancer Genetics 13D Filing From FiveT Investment Shows 0% Stake In Co. Benzinga

Feb 16, 2021

04:45PM EST Cancer Genetics Announces Closing of $17.5 Million Common Stock GlobeNewswire Inc

Feb 11, 2021

11:26AM EST Mid-Morning Market Update: RCM Technologies Shares Spike Higher, Even As Walt Disney Prepares to Announce Q1 Results Benzinga

Feb 10, 2021

11:00PM EST Cancer GeneticsAnnounces $17.5 Million Common Stock GlobeNewswire Inc

03:12PM EST Mid-Afternoon Market Update: Dow Surges Over 100 Points; Panbela Therapeutics Shares Plunge Benzinga

03:11PM EST Mid-Day Market Update: US Stocks Turn Lower; Bio-Path Shares Jump Benzinga

06:51AM EST Cancer Genetics Shares +223% Premarket; Traders Citing Monday Filing Mentioning Proposed Merger of Co With StemoniX Benzinga

06:51AM EST Cancer Genetics Shares Up 175% Premarket; Monday Filing Shows Co. Has Entered Into Merger Agreement With StemoniX Benzinga

Feb 6, 2021

11:52AM EST INVESTIGATION ALERT: Halper Sadeh LLP Investigates NK, ALXN, CATM, CGIX, MTSC; PR Newswire

Feb 1, 2021

05:16PM EST Cancer GeneticsAnnounces Closing of $10.0 Million GlobeNewswire Inc

Jan 30, 2021

07:06PM EST Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders PR Newswire

Jan 29, 2021

07:45AM EST The Daily Biotech Pulse: Novavax Vaccine Readout, Clinical Hold On Bellicum Study Lifted, Lilly Earnings, NLS Pharma IPO Benzinga

Jan 28, 2021

05:11PM EST Cancer Genetics shares were trading higher after the company reported a $10 million private placement priced at the market. Benzinga

04:05PM EST Cancer Genetics Reports $10M Private Placement Priced At The Market Benzinga

Jan 21, 2021

10:11AM EST Mid-Morning Market Update: Markets Mixed; Union Pacific Profit Beats Views Benzinga

Jan 16, 2021

02:55PM EST Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: GlobeNewswire Inc

Jan 14, 2021

05:27PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds CGIX, NPA, THBR and GIX Shareholders PR Newswire

Jan 9, 2021

10:29AM EST Halper Sadeh LLP Investigates the Following Mergers; Shareholders are PR Newswire

Jan 7, 2021

04:06PM EST SHAREHOLDER ALERT: WeissLaw LLP Reminds FIII, JWS, BRPA, and CGIX Shareholders PR Newswire

04:05PM EST Cancer Genetics, Inc. (the Company) (Nasdaq: CGIX), an emerging leader in novel drug discovery techniques, announced today that Jay Roberts, Chief Executive Officer, will present at the 2021 BioConnect Virtual Conference hosted by H.C. Wainwright. Registered attendees can access the recorded presentation on-demand (24x7) for the duration of the conference. GlobeNewswire Inc

08:37AM EST Cancer Genetics On January 4, Got Notice From Nasdaq Notifying Co That It No Longer Complies With Nasdaq Listing Rule Benzinga

Dec 19, 2020

04:17PM EST SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following PR Newswire

Dec 18, 2020

10:28PM EST WeissLaw LLP Reminds EIGI, GV, CGIX and ROCH Shareholders About Its Ongoing PR Newswire

Dec 8, 2020

12:12PM EST Merger Investigations; Investors are Encouraged to Contact the Firm - ANH, GV, ALSK, CLCT, CGIX PR Newswire

Dec 7, 2020

04:54PM EST WeissLaw LLP Reminds CGIX, ALSK, EIGI, and HDS Shareholders About Its Ongoing PR Newswire

Dec 1, 2020

07:15PM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: GlobeNewswire Inc

Nov 30, 2020

08:50PM EST WeissLaw LLP Reminds CGIX, ALSK, EIGI, and HDS Shareholders About Its Ongoing PR Newswire

Nov 18, 2020

08:00AM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: GlobeNewswire Inc

Nov 17, 2020

12:10PM EST Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm PR Newswire

Nov 13, 2020

10:37PM EST Halper Sadeh LLP, a global investor rights law firm, announces it is investigating: GlobeNewswire Inc

Nov 12, 2020

05:31PM EST SHAREHOLDER ALERT: WeissLaw LLP Investigates Cancer Genetics, Inc. PR Newswire

04:32PM EST Cancer Genetics Q3 EPS $(0.58) Up From $(0.82) YoY, Sales $1.57M Down From $2.07M YoY Benzinga

12:25PM EST Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies: GlobeNewswire Inc

Nov 9, 2020

10:42AM EST Cancer Genetics 13D Filing From FiveMore Fund Show 3.82% Stake In Co. Benzinga

Nov 2, 2020

04:00PM EST Cancer Genetics, Inc. Announces Closing of Public Offering and GlobeNewswire Inc

Oct 29, 2020

02:34PM EDT Mid-Afternoon Market Update: Dow Surges Over 300 Points; Inphi Shares Spike Higher Benzinga

12:24PM EDT Mid-Day Market Update: Crude Oil Down 4%; Pinterest Shares Jump On Upbeat Results Benzinga

10:20AM EDT Mid-Morning Market Update: Markets Mostly Higher; Kraft Heinz Beats Q3 Views Benzinga

07:30AM EDT The Daily Biotech Pulse: Novartis Acquires Gene Therapy Company, Moderna's Japanese Vaccine Supply Deal Benzinga

Oct 28, 2020

05:59PM EDT Cancer Genetics Announces $2M Bought Deal Offering Priced $2.20/Share Benzinga

Oct 19, 2020

03:24PM EDT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

Oct 9, 2020

08:01AM EDT Holdings, Inc. (NYSE: ARA), BMC Stock Holdings, Inc., Builders FirstSource, Inc., Cancer Genetics, Inc., Cellular Biomedicine Group, Inc., Eidos Therapeutics, Inc., Montage Resources Corporation, MyoKardia, Inc. and Yintech Investment Holdings Limited PR Newswire

Oct 2, 2020

08:01PM EDT BMC Stock Holdings, Inc. (NASDAQ:BMCH) - Builders FirstSource, Inc. (NASDAQ:BLDR) GlobeNewswire Inc

Sep 26, 2020

03:01AM EDT Ongoing Investigations; Investors are Encouraged to Contact the Firm - CGIX, YIN, OTEL, BMCH PR Newswire

Sep 25, 2020

04:55PM EDT (NASDAQ: AKCA), BMC Stock Holdings, Inc. (NASDAQ: BMCH), Builders FirstSource, Inc. (NASDAQ: BLDR), Cancer Genetics, Inc. (NASDAQ: CGIX), Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Otelco Inc. (NASDAQ: OTEL), Rosetta Stone Inc. (NYSE: RST), Varian Medical Systems, Inc. (NYSE: VAR), and Yintech Investment Holdings Limited (NASDAQ: YIN) PR Newswire

Sep 24, 2020

10:48AM EDT Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies: GlobeNewswire Inc

Sep 23, 2020

03:00PM EDT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

Sep 16, 2020

01:25PM EDT Lifshitz Law Firm, P.C. Announces Investigation of Aimmune GlobeNewswire Inc

Sep 10, 2020

08:50PM EDT Akcea Therapeutics, Inc., BMC Stock Holdings, Inc., Builders FirstSource, Inc., Broadway Financial Corporation, Cancer Genetics, Inc., Proteostasis Therapeutics, Inc., Rosetta Stone Inc., and Yintech Investment Holdings Limited PR Newswire

08:00AM EDT Cancer Genetics, Inc. (the Company) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced it will present at the 22nd Annual Rodman & Renshaw Global Investment Conference sponsored by H.C. Wainwright & Co., LLC.The conference is being heldvirtually from September 14-16, 2020. GlobeNewswire Inc

Sep 3, 2020

10:48AM EDT Cancer Genetics shares are trading higher after it and StemoniX announced a joint proof-of-concept program. Benzinga

08:06AM EDT Cancer Genetics And StemoniX Announce Joint Proof-of-Concept Program Benzinga

08:00AM EDT Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, and StemoniX, Inc., a company empowering the discovery of new medicines through the convergence of novel human biology and software technologies, today announced a joint proof-of-concept program. GlobeNewswire Inc

Sep 2, 2020

08:00PM EDT SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of GlobeNewswire Inc

Sep 1, 2020

07:17PM EDT Lifshitz Law Firm, P.C. Announces Investigation of Cancer GlobeNewswire Inc

Aug 31, 2020

11:37AM EDT INVESTOR ALERT: Monteverde & Associates PC Announces an Investigation of Cancer PR Newswire

Aug 27, 2020

11:00AM EDT Moore Kuehn, PLLC, a securities litigation law firm located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders. Moore Kuehn may ultimately seek increased consideration, additional disclosures, or other relief and benefits on behalf of the shareholders of these companies: GlobeNewswire Inc

Aug 26, 2020

06:39PM EDT Jernigan Capital, Inc., Momenta Pharmaceuticals, Inc., NTN Buzztime, Inc., Principia Biopharma Inc., Spring Bank Pharmaceuticals, Inc., Varian Medical Systems, Inc., and Yintech Investment Holdings Limited PR Newswire

06:09PM EDT CANCER GENETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cancer Genetics, Inc. - CGIX Business Wire

Aug 25, 2020

11:59AM EDT Mid-Morning Market Update: Markets Mostly Lower; Hormel Foods Earnings Top Views Benzinga

06:20AM EDT Into Whether the Merger of Cancer Genetics, Inc. is Fair to Shareholders; Investors are Encouraged to Contact the Firm PR Newswire

Aug 24, 2020

03:42PM EDT Why Cancer Genetics Is Trading Higher Today Benzinga

02:51PM EDT Mid-Afternoon Market Update: MOGU Falls After Q1 Results; Cancer Genetics Shares Jump Benzinga

12:01PM EDT Mid-Day Market Update: Dow Rises 1%; Sonnet BioTherapeutics Shares Spike Higher Benzinga

10:20AM EDT Mid-Morning Market Update: Markets Open Higher; FDA Issues Emergency Use Authorization For Convalescent Plasma To Treat Coronavirus Benzinga

09:06AM EDT Shares of Cancer Genetics Inc. (CGIX) are soaring over 213% in pre-market today, after the company announced a definitive merger agreement with StemoniX Inc. RTTNews

08:17AM EDT Cancer Genetics Shareholders to Own 22% of the Combined Company Following Merger with StemoniX Benzinga

08:02AM EDT Cancer Genetics and StemoniX Sign Definitive Agreement To Merge Benzinga

08:00AM EDT Combined Company Positioned to Offer Best-in-Class and Innovative Drug Discovery Solutions GlobeNewswire Inc

Aug 14, 2020

07:34AM EDT Cancer Genetics Q2 EPS $(0.82) Down From $(0.01) YoY, Sales $1.40M Down From $1.52M YoY Benzinga

07:30AM EDT Cancer Genetics, Inc. (the Company) (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, announced yesterday financial and operating results for the quarter ended June 30, 2020. GlobeNewswire Inc

Share